Egyptian Healthtech Reme-D Raises $1.45 Million Pre-Series A for Molecular Diagnostics

Egyptian startup Reme-D has raised $1.45 million in a pre-Series A round to develop affordable molecular diagnostic tools targeting tuberculosis, HIV, and HPV. The raise is directed at closing an affordability gap in infectious disease diagnosis across underserved African healthcare markets.